Cann Group Ltd has released a press release.
Cann releases FY22 results
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cann
- GMP manufacturing licence granted for Mildura
- Monthly Activities/Appendix 4C Cash Flow Report
- New funding arrangements with National Australia Bank
- ODC manufacture permit granted for Mildura
- Evaluation and option agreement with GSK Consumer Healthcare
Later from Cann
- Scope of Mildura GMP licence extended
- Chief Executive Officer role update
- Share Purchase Plan
- Amended Quarterly Activities Report
- Cann Group and Haleon sign non-binding term sheet
Follow Cann into a list and get an email when it puts out news.
Follow Cann